JP2001504479A5 - - Google Patents

Download PDF

Info

Publication number
JP2001504479A5
JP2001504479A5 JP1998523345A JP52334598A JP2001504479A5 JP 2001504479 A5 JP2001504479 A5 JP 2001504479A5 JP 1998523345 A JP1998523345 A JP 1998523345A JP 52334598 A JP52334598 A JP 52334598A JP 2001504479 A5 JP2001504479 A5 JP 2001504479A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998523345A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001504479A (ja
Filing date
Publication date
Priority claimed from GBGB9623860.5A external-priority patent/GB9623860D0/en
Priority claimed from GBGB9708062.6A external-priority patent/GB9708062D0/en
Application filed filed Critical
Priority claimed from PCT/GB1997/003154 external-priority patent/WO1998022460A1/en
Publication of JP2001504479A publication Critical patent/JP2001504479A/ja
Publication of JP2001504479A5 publication Critical patent/JP2001504479A5/ja
Ceased legal-status Critical Current

Links

JP52334598A 1996-11-15 1997-11-17 二環式アリールカルボキシアミド及びその治療的使用 Ceased JP2001504479A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9623860.5A GB9623860D0 (en) 1996-11-15 1996-11-15 Novel compounds
GB9623860.5 1996-11-15
GBGB9708062.6A GB9708062D0 (en) 1997-04-22 1997-04-22 Novel compounds
GB9708062.6 1997-04-22
PCT/GB1997/003154 WO1998022460A1 (en) 1996-11-15 1997-11-17 Bicyclic aryl carboxamides and their therapeutic use

Publications (2)

Publication Number Publication Date
JP2001504479A JP2001504479A (ja) 2001-04-03
JP2001504479A5 true JP2001504479A5 (enExample) 2005-07-14

Family

ID=26310411

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52334598A Ceased JP2001504479A (ja) 1996-11-15 1997-11-17 二環式アリールカルボキシアミド及びその治療的使用

Country Status (22)

Country Link
US (2) US6353010B1 (enExample)
EP (1) EP0944616B1 (enExample)
JP (1) JP2001504479A (enExample)
KR (1) KR20000053274A (enExample)
CN (1) CN1114604C (enExample)
AT (1) ATE242234T1 (enExample)
AU (1) AU726590B2 (enExample)
BR (1) BR9713507A (enExample)
CA (1) CA2268037A1 (enExample)
CZ (1) CZ158299A3 (enExample)
DE (1) DE69722656T2 (enExample)
DK (1) DK0944616T3 (enExample)
ES (1) ES2200163T3 (enExample)
HU (1) HUP0000189A3 (enExample)
ID (1) ID21698A (enExample)
IL (1) IL129337A0 (enExample)
NO (1) NO992337L (enExample)
NZ (1) NZ335197A (enExample)
RU (1) RU2176642C2 (enExample)
SK (1) SK283534B6 (enExample)
TR (1) TR199901730T2 (enExample)
WO (1) WO1998022460A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000198734A (ja) * 1998-12-30 2000-07-18 Pfizer Inc 胃運動性減弱および関連疾患の治療のための運動性増強薬
GB0003254D0 (en) * 2000-02-11 2000-04-05 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
GB0003256D0 (en) 2000-02-11 2000-04-05 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
KR20040010713A (ko) * 2001-06-15 2004-01-31 야마노우치세이야쿠 가부시키가이샤 페닐피리딘 카보닐 피페라진 유도체
US20040131614A1 (en) * 2002-07-19 2004-07-08 Abbott Biotechnology Ltd. Treatment of pulmonary disorders using TNFalpha inhibitor
CN1902193B (zh) 2003-12-04 2011-07-13 沃泰克斯药物股份有限公司 可用作蛋白激酶抑制剂的喹喔啉
US20070225308A1 (en) * 2004-03-15 2007-09-27 Kyowa Hakko Kogyo Co.,Ltd. 2-Amino Quinazoline Derivative
AU2006214184B2 (en) * 2005-02-17 2012-02-02 Albany Molecular Research, Inc. Benzoxazole carboxamides for treating CINV and IBS-D
US20060223849A1 (en) * 2005-03-14 2006-10-05 Mjalli Adnan M Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
JP5757495B2 (ja) 2005-05-16 2015-07-29 アッヴィ バイオテクノロジー リミテッド びらん性多発性関節炎の治療のためのtnf阻害剤の使用
MX2008010645A (es) * 2006-02-20 2008-10-14 Astellas Pharma Inc Derivado de amida o sal del mismo.
US9605064B2 (en) 2006-04-10 2017-03-28 Abbvie Biotechnology Ltd Methods and compositions for treatment of skin disorders
WO2008063213A2 (en) 2006-04-10 2008-05-29 Abbott Biotechnology Ltd. Uses and compositions for treatment of psoriatic arthritis
WO2008019363A2 (en) * 2006-08-07 2008-02-14 Albany Molecular Research, Inc. 2-alkylbenzoxazole carboxamides as 5ht3 modulators
US20100056791A1 (en) * 2006-09-01 2010-03-04 Yasushi Kohno Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same
NZ575410A (en) * 2006-09-07 2012-03-30 Biogen Idec Inc 2-(1H-Indazol-3-ylamino)-1H-benzimidazole derivatives
EP2171451A4 (en) 2007-06-11 2011-12-07 Abbott Biotech Ltd METHOD FOR TREATING JUVENILIAN IDIOPATHIC ARTHRITIS
CL2008001933A1 (es) 2007-06-29 2009-09-25 Millennium Pharm Inc Compuestos derivados de pirimidina, inhibidores de la raf quinasa; compuestos intermediarios; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar trastornos proliferativos, cardiacos, neurodegenerativos, inflamatorios, oseos, inmunologicos enfermedad viral, entre otros.
CA2752885A1 (en) 2009-02-27 2010-09-02 Ambit Biosciences Corporation Jak kinase modulating quinazoline derivatives and methods of use thereof
EP2611789A1 (en) 2010-09-01 2013-07-10 Ambit Biosciences Corporation Quinazoline compounds and methods of use thereof
CA2874303C (en) * 2012-06-11 2020-10-13 Ucb Biopharma Sprl Tnf -alpha modulating benz imidazoles
WO2014037340A1 (de) * 2012-09-05 2014-03-13 Bayer Cropscience Ag Verwendung substituierter 2-amidobenzimidazole, 2-amidobenzoxazole und 2-amidobenzothiazole oder deren salze als wirkstoffe gegen abiotischen pflanzenstress
CN108440333A (zh) * 2018-03-29 2018-08-24 江苏道博化工有限公司 分散染料中间体的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50140442A (enExample) 1974-04-16 1975-11-11
EP0116938A1 (en) 1983-02-14 1984-08-29 Usv Pharmaceutical Corporation Benzoheterocyclic carbamates
DE3835660A1 (de) * 1988-03-25 1989-10-12 Bayer Ag 7-substituierte 2-carbonamido-benzthiazol-3-oxide
DE4014937A1 (de) 1990-05-10 1991-11-14 Bayer Ag 2,3-disubstituierte chinoxaline als leistungsfoerderer fuer tiere
GB9219634D0 (en) 1992-09-16 1992-10-28 Ici Plc Heterocyclic compounds
GB9219632D0 (en) 1992-09-16 1992-10-28 Ici Plc Heterocyclic compounds
AU675680B2 (en) 1992-10-14 1997-02-13 Merck & Co., Inc. Fibrinogen receptor antagonists
DE4237617A1 (de) 1992-11-06 1994-05-11 Bayer Ag Verwendung von substituierten Benzimidazolen
GB9301660D0 (en) 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
GB9306578D0 (en) 1993-03-30 1993-05-26 Merck Sharp & Dohme Therapeutic agents
ES2152414T3 (es) * 1994-07-22 2001-02-01 Byk Gulden Lomberg Chem Fab Dihidrobenzofuranos.
US6083961A (en) 1994-08-03 2000-07-04 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole compounds as bradykinin antagonists
AU699489B2 (en) * 1994-10-12 1998-12-03 Euro-Celtique S.A. Novel benzoxazoles
US5665737B1 (en) 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles

Similar Documents

Publication Publication Date Title
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2000501324A5 (enExample)
JP2001503739A5 (enExample)
JP2000500026A5 (enExample)
JP2000502472A5 (enExample)
JP2000501338A5 (enExample)
JP2000501825A5 (enExample)
JP2000500874A5 (enExample)
JP2001523361A5 (enExample)
JP2000502485A5 (enExample)
JP2000502425A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000516211A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000500857A5 (enExample)
JP2000502714A5 (enExample)
JP2000500184A5 (enExample)